News

FDA names first-ever AI chief
Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.
COVID Boosters Might Not Be Updated for Next Season, FDA Commissioner Says
By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- The head of the U.S. Food and Drug ...
FDA's top inspector abruptly retires
The Food and Drug Administration's top official overseeing drug and food safety inspections told staff on Monday he has ...
Novo Nordisk cuts forecasts, shares rise ahead of FDA ban on Wegovy copycats
Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) - Obesity drugmaker Novo Nordisk cut its sales forecasts on Wednesday ...
FDA to boost surprise inspections at foreign-based food, medical plants
The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...
MedPage Today18h
Wegovy Pill Under Review; FDA Lifts Obesity Trial Clinical Hold; SGLT2s and Surgery
The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...
Exclusive: US cancels FDA bargaining session over layoffs, union says
The Trump administration last week canceled the first bargaining session scheduled with the U.S. Food and Drug Administration ...
Nut Recall Update as FDA Issues Highest Risk Warning
The mislabeling of allergens is a leading cause of food recalls in the U.S., and can have serious or life-threatening ...